Alex Gorsky formally became Johnson & Johnson’s CEO today, amid ongoing trouble with product recalls, manufacturing problems and government inquiries. Mr. Gorsky plans to rethink how the company develops new drugs and raise the bar on innovation, according to the report.
More Articles on Orthopedic Devices:
AlloSource Hires Dale Binke as Vice President of Marketing & Sales
Orthofix Sells Sports Medicine Business for $157.5M
Johnson & Johnson Q1 Orthopedic Sales Flat
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.